Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease

OBJECTIVE: Recommendations for the diagnosis of preclinical Alzheimer disease (AD) have been formulated by a workgroup of the National Institute on Aging and Alzheimer's Association. Three stages of preclinical AD were described. Stage 1 is characterized by abnormal levels of β-amyloid. Stage 2...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Knopman, D.S., Jack, C.R., Wiste, H.J., Weigand, S.D., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J.L., Senjem, M.L., Ivnik, R.J., Roberts, R.O., Boeve, B.F., Petersen, R.C.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2012
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3348848/
https://ncbi.nlm.nih.gov/pubmed/22551733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182563bbe
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars